The Importance of Human Dose And PK Prediction As Early As Possible

Time: 11:50 am - 12:10 pm

Date: 30 April 2019

30-april-2019 11:50 30-april-2019 12:10 Europe/London The Importance of Human Dose And PK Prediction As Early As Possible

Any research organisation working towards bringing a new medicine to market will want to know as early as possible “can this compound be a drug?”. The key to this is sufficient potency against the target, an acceptable safety margin coupled with commensurate DMPK properties to allow a sufficiently low dose. Richard will present on how… Read more »

Making Pharmaceuticals

Synopsis

Any research organisation working towards bringing a new medicine to market will want to know as early as possible “can this compound be a drug?”. The key to this is sufficient potency against the target, an acceptable safety margin coupled with commensurate DMPK properties to allow a sufficiently low dose. Richard will present on how DMPK understanding and influence is needed at the early stages of R&D and how a human dose prediction can be made early in drug discovery and refined in the pre-clinical development phase.

Speakers

« Back